OC-X treatments also caused surge upregulation of several important biomarkers within each cancer progression stage, including UCP1, NOSTRIN, SCGB3A1, ENG, EPAS1, SFTPD, and BMP4 (Figure 5A). Here, ENG is linked to cancer.